Clinical trial

Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients…

NCT00084695 · Milton S. Hershey Medical Center, Other · Unknown status

Key facts

NCT number NCT00084695
Title Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
Official title The Use Of Umbilical Cord Blood As A Source Of Hematopoietic Stem Cells
Lead sponsor Milton S. Hershey Medical Center, Other
Status Unknown status
Phase Phase 2
Study type Interventional
Conditions Childhood Langerhans Cell Histiocytosis, Fanconi Anemia, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
Intervention type Biological, Drug, Radiation
Interventions anti-thymocyte globulin, busulfan, cyclophosphamide, fludarabine phosphate, melphalan, methylprednisolone, radiation therapy
Enrollment 25
Start date Sep 1, 2003
Primary completion Dec 1, 2012
First posted Jun 11, 2004
Last update posted Jan 10, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies